These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2291005)

  • 21. [Immunophenotyping in the differential diagnosis of malignant non-hodgkin's lymphomas].
    Dzembak TM; Gurkalo VK; Gershanovich ML
    Vopr Onkol; 1996; 42(5):63-6. PubMed ID: 9064906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germinal centre cell kinetics.
    Hollowood K; Goodlad JR
    J Pathol; 1998 Jul; 185(3):229-33. PubMed ID: 9771474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A history of the Reed-Sternberg cell.
    Taylor CR
    Biomedicine; 1978; 28(4):196-203. PubMed ID: 737271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.
    Linder J; Ye Y; Armitage JO; Weisenburger DD
    Mod Pathol; 1988 Jan; 1(1):29-34. PubMed ID: 3266335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
    Weiss LM; Yousem SA; Warnke RA
    Am J Surg Pathol; 1985 Jul; 9(7):480-90. PubMed ID: 3879107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic classification of non-Hodgkin's lymphomas: current status.
    Seligmann M; Brouet JC; Preud'homme JL
    Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
    Kalyan K; Basu D; Soundararaghavan J
    Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas.
    Poppema S; van den Berg A
    Semin Cancer Biol; 2000 Oct; 10(5):345-50. PubMed ID: 11100882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies.
    Dobson CM; Myskow MW; Krajewski AS; Carpenter FH; Horne CH
    J Pathol; 1987 Nov; 153(3):203-12. PubMed ID: 3323430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fas ligand expression in nodal non-Hodgkin's lymphoma.
    Müllauer L; Mosberger I; Chott A
    Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [T-cell-rich B-cell lymphoma: multifactorial study of 4 cases].
    Moreno MM; Fernández-Flores A; Paradela A; Rodríguez JM; Ageitos A; Gonzalo I; Marcos B; Robledo M; Rivas C
    Sangre (Barc); 1995 Dec; 40(6):471-7. PubMed ID: 8850230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hodgkin's disease--immunological aspects].
    Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
    Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ultrastructural characteristics of malignant non-Hodgkin's lymphoma in baboons].
    Bukaeva IA; Iakovleva LA; Lapin BA; Kove EM
    Arkh Patol; 1984; 46(5):51-9. PubMed ID: 6331815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clonal proliferation of less mature granulocytic precursors (CFU-dG) under the influence of neoplastic B lymphocytes in low grade non-hodgkin's lymphomas].
    Kozłowska-Skrzypczak M; Hansz J
    Acta Haematol Pol; 1992; 23(4):259-66. PubMed ID: 1293907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.